This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Missouri. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Eric D Queathem: Innovator in Obesity Treatment
Introduction
Eric D Queathem is a notable inventor based in Columbia, MO (US). He has made significant contributions to the field of obesity treatment through his innovative research and patent.
Latest Patents
Eric D Queathem holds a patent for a drug combination aimed at treating obesity. The patent describes methods for addressing obesity, pre-diabetes, diabetes, and obese breast cancer by enhancing mitochondrial metabolism. This is achieved by increasing the activity of uncoupling protein 1 (UCP1) in adipocytes. The methods involve the use of an adrenergic receptor agonist in adipocytes where the genomic activity of estrogen receptor beta (ERβ) has been inhibited or inactivated. The invention highlights the potential of targeting ERβ to improve treatment outcomes.
Career Highlights
Eric is affiliated with the University of Missouri, where he conducts his research. His work focuses on innovative approaches to combat obesity and related health issues. His dedication to advancing medical science is evident in his research and patent contributions.
Collaborations
Eric has collaborated with esteemed colleagues, including Victoria J Vieira-Potter and Dennis B Lubahn. These partnerships enhance the depth and impact of his research in the field.
Conclusion
Eric D Queathem is a pioneering inventor whose work in obesity treatment showcases the intersection of innovation and health. His contributions are vital in the ongoing battle against obesity and its associated health challenges.